Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase

Author(s): Medha Priyadarshini, Mohammad A. Kamal, Nigel H. Greig, Marcella Realef, Adel M. Abuzenadah, Adeel G.A. Chaudhary, Ghazi A. Damanhouri

Journal Name: CNS & Neurological Disorders - Drug Targets
Formerly Current Drug Targets - CNS & Neurological Disorders

Volume 11 , Issue 4 , 2012

Become EABM
Become Reviewer
Call for Editor


Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) are two debilitating health disorders afflicting millions worldwide. Recent research has revealed similarities between AD and T2DM. Both these protein conformational disorders are associated with obesity, insulin resistance, inflammation and endoplasmic reticulum stress, en-route initiation and/or stage aggravation. In this mini review we have tried to summarize studies describing obesity, insulin resistance and glucocorticoid imbalance as common patho-mechanisms in T2DM and AD. A reduction in tyrosine hydroxylase (TH) in the brain has been found to occur in Parkinson’s disease (PD). AD, T2DM and PD share common risk factors like depression. Thus, whether TH is involved in the ‘state of cognitive depression’ that is the hallmark of AD and often accompanies PD and T2DM is also explored.

Keywords: Type 2 diabetes mellitus, Alzheimer’s disease, Parkinson’s disease, neurodegeneration, tyrosine hydroxylase, dementia, obesity, insulin resistance, metabolic syndrome, neuroinflammation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 29 May, 2012
Page: [482 - 489]
Pages: 8
DOI: 10.2174/187152712800792767
Price: $65

Article Metrics

PDF: 20